Skip to main content

Pfizer-BioNTech COVID-19 booster shot was 95.6% effective in large trial, companies say

By The Wall Street Journal  
   October 21, 2021

A third dose of the COVID-19 vaccine from Pfizer Inc. and BioNTech was found in a large study to be highly protective against symptomatic COVID-19, the companies said Thursday.

Full story

Get the latest on healthcare leadership in your inbox.